Kenneth O'Byrne

14PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer geneticsBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 26, 2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

|Dec 13, 2025
Frontline sigvotatug vedotin plus pembrolizumab vs pembrolizumab for non-small cell lung cancer with PD-L1 tumor proportion score ≥50%: phase III study design.

Martin Reck, Shun Lu, Kenneth J O'Byrne

|Aug 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery.

Kortnye Smith, Sophie O'Haire, Benjamin Markman

|Apr 22, 2024
Sequence- and Structure-Dependent Cytotoxicity of Phosphorothioate and 2'-<i>O</i>-Methyl Modified Single-Stranded Oligonucleotides.

Laura V Croft, Mark Fisher, Tabassum Khair Barbhuiya

|Feb 28, 2024
Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer.

A P Wiegmans, E Ivanova, V Y Naei

|Jan 24, 2023
Structural investigation of CDCA3-Cdh1 protein-protein interactions using in vitro studies and molecular dynamics simulation.

Tabassum Khair Barbhuiya, Mark Fisher, Eric D Boittier

Pageof 3

Frequent Collaborators

7 joint publications

Arutha Kulasinghe

5 joint publications

James Monkman

5 joint publications

Majid Ebrahimi Warkiani

2 joint publications

Martin Reck